A citation-based method for searching scientific literature

Vlado Perkovic, Dick de Zeeuw, Kenneth W Mahaffey, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Terrance D Barrett, Michele Weidner-Wells, Hsiaowei Deng, David R Matthews, Bruce Neal. Lancet Diabetes Endocrinol 2018
Times Cited: 227







List of co-cited articles
825 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions.
Susan Michie, Michelle Richardson, Marie Johnston, Charles Abraham, Jill Francis, Wendy Hardeman, Martin P Eccles, James Cane, Caroline E Wood. Ann Behav Med 2013
1

Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
Abhinav Sharma, Neha J Pagidipati, Robert M Califf, Darren K McGuire, Jennifer B Green, Dave Demets, Jyothis Thomas George, Hertzel C Gerstein, Todd Hobbs, Rury R Holman,[...]. Circulation 2020
16
6

Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines-Heart Failure Registry.
Abhinav Sharma, Xin Zhao, Bradley G Hammill, Adrian F Hernandez, Gregg C Fonarow, G Michael Felker, Clyde W Yancy, Paul A Heidenreich, Justin A Ezekowitz, Adam D DeVore. Circ Heart Fail 2018
64
1

Embracing the Long Road to Precision Medicine.
Julio A Chirinos, David E Lanfear. Circ Heart Fail 2018
2
50

Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns.
João Pedro Ferreira, Kevin Duarte, John J V McMurray, Bertram Pitt, Dirk J van Veldhuisen, John Vincent, Tariq Ahmad, Jasper Tromp, Patrick Rossignol, Faiez Zannad. Circ Heart Fail 2018
10
10

Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options.
Jeffrey W Olin, Christopher J White, Ehrin J Armstrong, Daniella Kadian-Dodov, William R Hiatt. J Am Coll Cardiol 2016
86
1

Phenotypes of prediabetes and stratification of cardiometabolic risk.
Norbert Stefan, Andreas Fritsche, Fritz Schick, Hans-Ulrich Häring. Lancet Diabetes Endocrinol 2016
99
1

Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes.
Alexandra J Lansky, Vivian G Ng, Akiko Maehara, Giora Weisz, Amir Lerman, Gary S Mintz, Bernard De Bruyne, Naim Farhat, Gary Niess, Ivana Jankovic,[...]. JACC Cardiovasc Imaging 2012
171
1

Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.
Joakim Alfredsson, Jennifer B Green, Susanna R Stevens, Shelby D Reed, Paul W Armstrong, M Angelyn Bethel, Samuel S Engel, Darren K McGuire, Frans Van de Werf, Irene Hramiak,[...]. Diabetes Obes Metab 2018
13
7


Clinical implications of chronic heart failure phenotypes defined by cluster analysis.
Tariq Ahmad, Michael J Pencina, Phillip J Schulte, Emily O'Brien, David J Whellan, Ileana L Piña, Dalane W Kitzman, Kerry L Lee, Christopher M O'Connor, G Michael Felker. J Am Coll Cardiol 2014
120
1

Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients.
Tariq Ahmad, Lars H Lund, Pooja Rao, Rohit Ghosh, Prashant Warier, Benjamin Vaccaro, Ulf Dahlström, Christopher M O'Connor, G Michael Felker, Nihar R Desai. J Am Heart Assoc 2018
56
1

Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
David P Kao, James D Lewsey, Inder S Anand, Barry M Massie, Michael R Zile, Peter E Carson, Robert S McKelvie, Michel Komajda, John J V McMurray, JoAnn Lindenfeld. Eur J Heart Fail 2015
114
1

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
Matthew A Cavender, Ph Gabriel Steg, Sidney C Smith, Kim Eagle, E Magnus Ohman, Shinya Goto, Julia Kuder, Kyungah Im, Peter W F Wilson, Deepak L Bhatt. Circulation 2015
236
1

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
Matthew M Y Lee, Katriona J M Brooksbank, Kirsty Wetherall, Kenneth Mangion, Giles Roditi, Ross T Campbell, Colin Berry, Victor Chong, Liz Coyle, Kieran F Docherty,[...]. Circulation 2021
37
2

Established and Emerging Roles of Biomarkers in Heart Failure.
Nasrien E Ibrahim, James L Januzzi. Circ Res 2018
60
1


Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.
Jackie Bosch, John W Eikelboom, Stuart J Connolly, Nancy Cook Bruns, Vivian Lanius, Fei Yuan, Frank Misselwitz, Edmond Chen, Rafael Diaz, Marco Alings,[...]. Can J Cardiol 2017
82
1

Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial.
João Pedro Ferreira, Abhinav Sharma, Cyrus Mehta, George Bakris, Patrick Rossignol, William B White, Faiez Zannad. Clin Res Cardiol 2021
7
14

Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction.
Carlos G Santos-Gallego, Ariana P Vargas-Delgado, Juan Antonio Requena-Ibanez, Alvaro Garcia-Ropero, Donna Mancini, Sean Pinney, Frank Macaluso, Samantha Sartori, Merce Roque, Fernando Sabatel-Perez,[...]. J Am Coll Cardiol 2021
36
2

Uric Acid and Diabetic Nephropathy Risk.
Michael Mauer, Alessandro Doria. Contrib Nephrol 2018
12
8

Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives.
Meng Lv, Zhuo Chen, Gaoyun Hu, Qianbin Li. Drug Discov Today 2015
52
1

Paricalcitol and endothelial function in chronic kidney disease trial.
Carmine Zoccali, Giuseppe Curatola, Vincenzo Panuccio, Rocco Tripepi, Patrizia Pizzini, Marica Versace, Davide Bolignano, Sebastiano Cutrupi, Raffaele Politi, Giovanni Tripepi,[...]. Hypertension 2014
76
1

ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice.
Greg H Tesch, Frank Y Ma, Yingjie Han, John T Liles, David G Breckenridge, David J Nikolic-Paterson. Diabetes 2015
48
2


Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Zhenzhen Li, Xianghua Liu, Baoying Wang, Yali Nie, Jianguo Wen, Qingwei Wang, Chaohui Gu. Nephrology (Carlton) 2017
48
2


TGF-β1/p53 signaling in renal fibrogenesis.
Stephen P Higgins, Yi Tang, Craig E Higgins, Badar Mian, Wenzheng Zhang, Ralf-Peter Czekay, Rohan Samarakoon, David J Conti, Paul J Higgins. Cell Signal 2018
46
2

MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
Jian Wu, Jibo Liu, Yaqin Ding, Mingying Zhu, Kan Lu, Jing Zhou, Xin Xie, Yi Xu, Xiaoyu Shen, Yiyue Chen,[...]. Biochem Biophys Res Commun 2018
32
3


Special Issue "Diabetic Nephropathy: Diagnosis, Prevention and Treatment".
Marta Ruiz-Ortega, Raul R Rodrigues-Diez, Carolina Lavoz, Sandra Rayego-Mateos. J Clin Med 2020
8
12

Normoalbuminuric diabetic kidney disease.
Chao Chen, Chang Wang, Chun Hu, Yachun Han, Li Zhao, Xuejing Zhu, Li Xiao, Lin Sun. Front Med 2017
32
3

Novel therapies for diabetic kidney disease.
David Z I Cherney, George L Bakris. Kidney Int Suppl (2011) 2018
20
5

DAPA-CKD: The Beginning of a New Era in Renal Protection.
David Z I Cherney, Subodh Verma. JACC Basic Transl Sci 2021
2
50


Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes.
Mark E Cooper, Vlado Perkovic, Janet B McGill, Per-Henrik Groop, Christoph Wanner, Julio Rosenstock, Uwe Hehnke, Hans-Juergen Woerle, Maximilian von Eynatten. Am J Kidney Dis 2015
61
1

Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases.
Heng Li, Jianping Zuo, Wei Tang. Front Pharmacol 2018
110
1

The role of heparanase in diseases of the glomeruli.
Maciej Szymczak, Jakub Kuźniar, Marian Klinger. Arch Immunol Ther Exp (Warsz) 2010
26
3

Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs.
Hiroko Sakuma, Shinji Hagiwara, Phillip Kantharidis, Tomohito Gohda, Yusuke Suzuki. Front Pharmacol 2020
1
100



Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy.
Kengo Furuichi, Miho Shimizu, Yukio Yuzawa, Akinori Hara, Tadashi Toyama, Hiroshi Kitamura, Yoshiki Suzuki, Hiroshi Sato, Noriko Uesugi, Yoshifumi Ubara,[...]. Clin Exp Nephrol 2018
14
7

The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy.
Claire E Hills, Paul E Squires. Cytokine Growth Factor Rev 2011
162
1

Role of Phosphodiesterase in the Biology and Pathology of Diabetes.
Agnieszka Kilanowska, Agnieszka Ziółkowska. Int J Mol Sci 2020
1
100

Transforming Growth Factor-Beta1 in Diabetic Kidney Disease.
Lijun Zhao, Yutong Zou, Fang Liu. Front Cell Dev Biol 2020
17
5

Coixol amplifies glucose-stimulated insulin secretion via cAMP mediated signaling pathway.
Abdul Hameed, Rahman M Hafizur, M Israr Khan, Abira Jawed, Hao Wang, Miaomiao Zhao, Kohichi Matsunaga, Tetsuro Izumi, Sonia Siddiqui, Faisal Khan,[...]. Eur J Pharmacol 2019
2
50

Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials.
Lennart Tonneijck, Marcel H A Muskiet, Mark M Smits, Petter Bjornstad, Mark H H Kramer, Michaela Diamant, Ewout J Hoorn, Jaap A Joles, Daniël H van Raalte. Diabetes Obes Metab 2018
10
10


RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
Zongshun Huang, Yonghua Peng, Hui Yu, Xiaomin Yu, Jialin Zhou, Jie Xiao. Biochem Biophys Res Commun 2018
8
12



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.